{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:49:38Z","timestamp":1771980578112,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Acromegaly is a rare pathology characterized by chronic hypersecretion of Growth Hormone (GH) and Insulin-like Growth Factor-1 (IGF-1) that causes somatic, metabolic, and systemic changes. The somatotropic axis acts physiologically favoring gonadal function, but when GH is produced in excess it has deleterious effects on many aspects of male sexuality. It is widely demonstrated, in fact, that acromegaly induces hypogonadism through different mechanisms, both through direct mass effect on gonadotropic cells and through increased plasma levels of prolactin. Moreover, hypogonadism is also one of the factors linking acromegaly to erectile dysfunction (ED), but also metabolic complications of acromegaly and, probably, GH itself contribute to the genesis of this disorder. There are few data in the literature on the impact of the disease on fertility and testicular volume. Finally, knowledge of the role of GH hypersecretion on the occurrence of prostatic diseases such as benign prostatic hypertrophy and prostatic cancer appears to be of fundamental clinical importance in the long-term management of these patients.<\/jats:p>","DOI":"10.1007\/s11154-022-09721-0","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T21:02:31Z","timestamp":1648846951000},"page":"671-678","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Acromegaly and male sexual health"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9290-5699","authenticated-orcid":false,"given":"Gianmaria","family":"Salvio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1752-1641","authenticated-orcid":false,"given":"Marianna","family":"Martino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1286-1521","authenticated-orcid":false,"given":"Giancarlo","family":"Balercia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6204-3423","authenticated-orcid":false,"given":"Giorgio","family":"Arnaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,1]]},"reference":[{"key":"9721_CR1","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1210\/jc.2014-2700","volume":"99","author":"L Katznelson","year":"2014","unstructured":"Katznelson L, Laws ER, Melmed S, Molitch ME, Murad MH, Utz A, et al. Acromegaly: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99:3933\u201351.","journal-title":"J Clin Endocrinol Metab"},{"key":"9721_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ecl.2006.11.009","volume":"36","author":"UJ Meinhardt","year":"2007","unstructured":"Meinhardt UJ, Ho KKY. Regulation of growth hormone action by gonadal steroids. Endocrinol Metab Clin North Am. 2007;36:57\u201373.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"9721_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1095\/biolreprod.103.027060","volume":"71","author":"V Chandrashekar","year":"2004","unstructured":"Chandrashekar V, Zaczek D, Bartke A. The consequences of altered somatotropic system on reproduction. Biol Reprod. 2004;71:17\u201327.","journal-title":"Biol Reprod"},{"key":"9721_CR4","first-page":"903","volume":"10","author":"J Baker","year":"1996","unstructured":"Baker J, Hardy MP, Zhou J, Bondy C, Lupu F, Bellv\u00e9 AR, et al. Effects of an Igf1 gene null mutation on mouse reproduction. Mol Endocrinol. 1996;10:903\u201318.","journal-title":"Mol Endocrinol"},{"key":"9721_CR5","doi-asserted-by":"publisher","first-page":"4397","DOI":"10.1210\/jcem.84.12.6255","volume":"84","author":"Z Laron","year":"1999","unstructured":"Laron Z. The essential role of IGF-I: Lessons from the long-term study and treatment of children and adults with Laron syndrome. J Clin Endocrinol Metab. 1999;84:4397\u2013404.","journal-title":"J Clin Endocrinol Metab"},{"key":"9721_CR6","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s11102-012-0420-x","volume":"16","author":"S Melmed","year":"2013","unstructured":"Melmed S, Casanueva FF, Klibanski A, Bronstein MD, Chanson P, Lamberts SW, et al. A consensus on the diagnosis and treatment of acromegaly complications. Pituitary. 2013;16:294\u2013302.","journal-title":"Pituitary"},{"key":"9721_CR7","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.12669\/pjms.37.7.4277","volume":"37","author":"SA Khan","year":"2021","unstructured":"Khan SA, Ram N, Masood MQ, Islam N. Prevalence of comorbidities among patients with Acromegaly. Pak J Med Sci. 2021;37:1758\u201361.","journal-title":"Pak J Med Sci"},{"key":"9721_CR8","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.21037\/gs-20-690","volume":"9","author":"J Zhang","year":"2020","unstructured":"Zhang J, Wang Y, Xu X, Gu Y, Huang F, Zhang M. Postoperative complications and quality of life in patients with pituitary adenoma. Gland Surg. 2020;9:1521\u20139.","journal-title":"Gland Surg"},{"key":"9721_CR9","doi-asserted-by":"crossref","unstructured":"do Amaral LC, Reis BL, Ribeiro-Oliveira A, da Silva Santos TM, Giannetti AV. Comparative study of complications after primary and revision transsphenoidal endoscopic surgeries. Neurosurg Rev. 2020.","DOI":"10.1007\/s10143-020-01360-w"},{"key":"9721_CR10","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/alr.21498","volume":"5","author":"MD Raikundalia","year":"2015","unstructured":"Raikundalia MD, Pines MJ, Svider PF, Baredes S, Folbe AJ, Liu JK, et al. Characterization of transsphenoidal complications in patients with acromegaly: An analysis of inpatient data in the United States from 2002 to 2010. Int Forum Allergy Rhinol. 2015;5:417\u201322.","journal-title":"Int Forum Allergy Rhinol"},{"key":"9721_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3171\/2018.7.GKS181589","volume":"129","author":"JW Oh","year":"2018","unstructured":"Oh JW, Sung KS, Moon JH, Kim EH, Chang WS, Jung HH, et al. Hypopituitarism after Gamma Knife surgery for postoperative nonfunctioning pituitary adenoma. J Neurosurg. 2018;129:47\u201354.","journal-title":"J Neurosurg"},{"key":"9721_CR12","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/nm1097-1141","volume":"3","author":"ST Ng","year":"1997","unstructured":"Ng ST, Zhou J, Adesanya OO, Wang J, LeRoith D, Bondy CA. Growth hormone treatment induces mammary gland hyperplasia in aging primates. Nat Med. 1997;3:1141\u20134.","journal-title":"Nat Med"},{"key":"9721_CR13","doi-asserted-by":"publisher","first-page":"e1290","DOI":"10.7205\/MILMED-D-15-00248","volume":"180","author":"DB Young","year":"2015","unstructured":"Young DB. 6\u20196\" United States marine seeks treatment for gynecomastia only to learn it is all in his head. Mil Med. 2015;180:e1290\u20132.","journal-title":"Mil Med"},{"key":"9721_CR14","doi-asserted-by":"publisher","first-page":"562","DOI":"10.4158\/EP-2018-0518","volume":"25","author":"Z Chen","year":"2019","unstructured":"Chen Z, Yu Y, He M, Shen M, Gong W, Wang M, et al. Higher growth hormone levels are associated with erectile dysfunction in male patients with acromegaly. Endocr Pract. 2019;25:562\u201371.","journal-title":"Endocr Pract"},{"key":"9721_CR15","doi-asserted-by":"crossref","unstructured":"Lotti F, Rochira V, Pivonello R, Santi D, Galdiero M, Maseroli E, et al. Erectile dysfunction is common among men with acromegaly and is associated with morbidities related to the disease. J Sex Med [Internet]. Blackwell Publishing Ltd; 2015 [cited 2020 Nov 1];12:1184\u201393. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/25736192\/.","DOI":"10.1111\/jsm.12859"},{"key":"9721_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-018-0051-2","volume":"5","author":"A Colao","year":"2019","unstructured":"Colao A, Grasso LFS, Giustina A, Melmed S, Chanson P, Pereira AM, et al. Acromegaly. Nat Rev Dis Prim. 2019;5:1\u201317.","journal-title":"Nat Rev Dis Prim"},{"key":"9721_CR17","doi-asserted-by":"publisher","unstructured":"Fan Y, Hu B, Man C, Cui F. Erectile dysfunction and risk of cardiovascular and all-cause mortality in the general population: a meta-analysis of cohort studies. World J Urol [Internet]. Springer Berlin Heidelberg; 2018;36:1681\u20139. Available from: https:\/\/doi.org\/10.1007\/s00345-018-2318-3.","DOI":"10.1007\/s00345-018-2318-3"},{"key":"9721_CR18","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/08037050510034293","volume":"14","author":"V Ronconi","year":"2005","unstructured":"Ronconi V, Giacchetti G, Mariniello B, Camilletti A, Mantero F, Boscaro M, et al. Reduced nitric oxide levels in acromegaly: Cardiovascular implications. Blood Press. 2005;14:227\u201332.","journal-title":"Blood Press"},{"key":"9721_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1530\/EJE-15-0888","volume":"174","author":"SA Imran","year":"2016","unstructured":"Imran SA, Tiemensma J, Kaiser SM, Vallis M, Doucette S, Abidi E, Yip CE, De Tugwell B, Siddiqi F, Clarke DB. Morphometric changes correlate with poor psychological outcomes in patients with acromegaly. Eur J Endocrinol. 2016;174:41\u201350.","journal-title":"Eur J Endocrinol"},{"key":"9721_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000448519","volume":"105","author":"C Dimopoulou","year":"2017","unstructured":"Dimopoulou C, Leistner SM, Ising M, Schneider HJ, Schopohl J, Rutz S, Kosilek R, Frohner R, Stalla GK, Sievers C. Body image perception in acromegaly is not associated with objective acromegalic changes but depends on depressive symptoms. Neuroendocrinology. 2017;105:115\u201322.","journal-title":"Neuroendocrinology"},{"key":"9721_CR21","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.ucl.2007.08.009","volume":"34","author":"A Makhlouf","year":"2007","unstructured":"Makhlouf A, Kparker A, Niederberger CS. Depression and erectile dysfunction. Urol Clin North Am. 2007;34:565\u201374.","journal-title":"Urol Clin North Am"},{"key":"9721_CR22","doi-asserted-by":"publisher","first-page":"4193","DOI":"10.1210\/jc.2002-020453","volume":"87","author":"A Colao","year":"2002","unstructured":"Colao A, De Rosa M, Pivonello R, Balestrieri A, Cappabianca P, Di Sarno A, et al. Short-term suppression of GH and IGF-I levels improves gonadal function and sperm parameters in men with acromegaly. J Clin Endocrinol Metab. 2002;87:4193\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"9721_CR23","first-page":"3754","volume":"85","author":"A Colao","year":"2000","unstructured":"Colao A, Marzullo P, Spiezia S, Giaccio A, Ferone D, Cerbone G, et al. Effect of two years of growth hormone and insulin-like growth factor-I suppression on prostate diseases in acromegalic patients. J Clin Endocrinol Metab. 2000;85:3754\u201361.","journal-title":"J Clin Endocrinol Metab"},{"key":"9721_CR24","doi-asserted-by":"publisher","unstructured":"Andreassen M, Juul A, Feldt-Rasmussen U, J\u00f8rgensen N. Semen quality in hypogonadal acromegalic patients. Pituitary [Internet]. Springer US; 2020;23:160\u20136. Available from: https:\/\/doi.org\/10.1007\/s11102-019-01018-x.","DOI":"10.1007\/s11102-019-01018-x"},{"key":"9721_CR25","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1054\/ghir.1999.0114","volume":"9","author":"MH Vickers","year":"1999","unstructured":"Vickers MH, Casey PJ, Champion ZJ, Gravance CG, Breier BH. IGF-I treatment increases motility and improves morphology of immature spermatozoa in the GH-deficient dwarf (dw\/dw) rat. Growth Horm IGF Res. 1999;9:236\u201340.","journal-title":"Growth Horm IGF Res"},{"key":"9721_CR26","doi-asserted-by":"publisher","unstructured":"Pedersen SA, J\u00f8rgensen JO, Christiansen JS, \u00d8rskov H, Skakkeb\u00e6k NE. Fertility and semen quality in previously growth hormone treated men. Pediatr Res [Internet]. 1988;23:120\u2013120. Available from: https:\/\/doi.org\/10.1203\/00006450-198801000-00111.","DOI":"10.1203\/00006450-198801000-00111"},{"key":"9721_CR27","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1530\/eje.0.1400224","volume":"140","author":"C Carani","year":"1999","unstructured":"Carani C, Granata ARM, De Rosa M, Garau C, Zarrilli S, Paesano L, et al. The effect of chronic treatment with GH on gonadal function in men with isolated GH deficiency. Eur J Endocrinol. 1999;140:224\u201330.","journal-title":"Eur J Endocrinol"},{"key":"9721_CR28","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/S0015-0282(16)58456-8","volume":"66","author":"P Ovesen","year":"1996","unstructured":"Ovesen P, Jorgensen JOL, Ingerslev J, Ho KKY, Orskov H, Christiansen JS. Growth hormone treatment of subfertile males. Fertil Steril. 1996;66:292\u20138.","journal-title":"Fertil Steril"},{"key":"9721_CR29","doi-asserted-by":"publisher","unstructured":"Shoham Z, Conway GS, Ostergaard H, Lahlou N, Bouchard P, Jacobs HS. Cotreatment with growth hormone for induction of spermatogenesis in patients with hypogonadotropic hypogonadism. Fertil Steril [Internet]. Elsevier Masson SAS; 1992;57:1044\u201351. Available from: https:\/\/doi.org\/10.1016\/S0015-0282(16)55023-7.","DOI":"10.1016\/S0015-0282(16)55023-7"},{"key":"9721_CR30","doi-asserted-by":"crossref","unstructured":"Lee K-O, Ng S-C, Lee P-S, Bongso AT, Taylor EA, Lin T-K, et al. Effect of growth hormone therapy in men with severe idiopathic oligozoospermia. Eur J Endocrinol [Internet]. BioScientifica Ltd.; 1995 [cited 2021 Jun 10];132:159\u201362. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/7858733\/.","DOI":"10.1530\/eje.0.1320159"},{"key":"9721_CR31","first-page":"269","volume":"49","author":"A Juul","year":"1998","unstructured":"Juul A, Andersson AM, Pedersen SA, J\u00f8rgensen JOL, Christiansen JS, Groome NP, et al. Effects of growth hormone replacement therapy on IGF-related parameters and on the pituitary-gonadal axis in GH-deficient males. A double-blind, placebo-controlled crossover study. Horm Res. 1998;49:269\u201378.","journal-title":"Horm Res"},{"key":"9721_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/andr.12444","volume":"6","author":"R Cannarella","year":"2018","unstructured":"Cannarella R, Condorelli RA, La Vignera S, Calogero AE. Effects of the insulin-like growth factor system on testicular differentiation and function: A review of the literature. Andrology. 2018;6:3\u20139.","journal-title":"Andrology"},{"key":"9721_CR33","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1080\/02688690400022797","volume":"18","author":"D Abraham","year":"2004","unstructured":"Abraham D, Couldwell WT. Bilateral testicular enlargement and seminoma in a patient with acromegaly. Br J Neurosurg. 2004;18:629\u201331.","journal-title":"Br J Neurosurg"},{"key":"9721_CR34","first-page":"1","volume":"95","author":"H Fang","year":"2016","unstructured":"Fang H, Xu J, Wu H, Fan H, Zhong L. Combination of Klinefelter syndrome and acromegaly. Med (United States). 2016;95:1\u20136.","journal-title":"Med (United States)"},{"key":"9721_CR35","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1210\/jc.2013-3826","volume":"99","author":"S Salenave","year":"2014","unstructured":"Salenave S, Boyce AM, Collins MT, Chanson P. Acromegaly and mccune-albright syndrome. J Clin Endocrinol Metab. 2014;99:1955\u201369.","journal-title":"J Clin Endocrinol Metab"},{"key":"9721_CR36","doi-asserted-by":"crossref","unstructured":"Aversa T, Zirilli G, Corica D, De Luca F, Wasniewska M. Phenotypic testicular abnormalities and pubertal development in boys with McCune-Albright syndrome. Ital J Pediatr. 2018;44:1\u20134.","DOI":"10.1186\/s13052-018-0577-7"},{"key":"9721_CR37","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0960-0760(95)00240-5","volume":"56","author":"M Motta","year":"1996","unstructured":"Motta M, Dondi D, Moretti RM, Marelli MM, Pimpinelli F, Maggi R, Limonta P. Role of growth factors, steroid and peptide hormones in the regulation of human prostatic tumor growth. J Steroid Biochem Mol Biol. 1996;56:107\u201311.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"9721_CR38","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1210\/er.2002-0022","volume":"25","author":"A Colao","year":"2004","unstructured":"Colao A, Ferone D, Marzullo P, Lombardi G. Systemic complications of acromegaly: Epidemiology, pathogenesis, and management. Endocr Rev. 2004;25:102\u201352.","journal-title":"Endocr Rev"},{"key":"9721_CR39","doi-asserted-by":"publisher","unstructured":"Nicholson TM, Ricke WA. Androgens and estrogens in benign prostatic hyperplasia: Past, present and future. Differentiation [Internet]. Elsevier; 2011;82:184\u201399. Available from: https:\/\/doi.org\/10.1016\/j.diff.2011.04.006.","DOI":"10.1016\/j.diff.2011.04.006"},{"key":"9721_CR40","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1210\/jcem.83.3.4645","volume":"83","author":"A Colao","year":"1998","unstructured":"Colao A, Marzullo P, Ferone D, Spiezia S, Cerbone G, Marin\u00f2 V, et al. Prostatic hyperplasia: An unknown feature of acromegaly. J Clin Endocrinol Metab. 1998;83:775\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"9721_CR41","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1210\/jcem.84.6.5776","volume":"84","author":"A Colao","year":"1990","unstructured":"Colao A, Marzullo P, Spiezia S, Ferone D, Giaccio A, Cerbone G, Pivonello R, et al. Effect of growth hormone (GH) and insulin-like growth factor I on prostate diseases: An ultrasonographic and endocrine study in acromegaly, GH deficiency, and healthy subjects. J Clin Endocrinol Metab. 1990;84:1986\u201391.","journal-title":"J Clin Endocrinol Metab"},{"key":"9721_CR42","first-page":"571","volume":"131","author":"LJ Hofland","year":"1992","unstructured":"Hofland LJ, van Koetsveld PM, Wouters N, Waaijers M, Reubi JC, Lamberts SWJ. Dissociation of antiproliferative and antihormonal effects of the somatostatin analog octreotide on 7315b pituitary tumor cells. Endocrinology. 1992;131:571\u20137.","journal-title":"Endocrinology"},{"key":"9721_CR43","doi-asserted-by":"crossref","unstructured":"Corr\u00eaa LL, Balarini Lima GA, Cavallieri SA, Miranda LCDD, Gadelha MR. Prostatic disorders in acromegalic patients experience of a Brazilian center. Int Braz J Urol.\u00a02013;39:393\u2013401.\u00a0","DOI":"10.1590\/S1677-5538.IBJU.2013.03.13"},{"key":"9721_CR44","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1530\/EJE-14-0698","volume":"172","author":"S Kumar","year":"2015","unstructured":"Kumar S, Yadav RN, Gupta P, Gaspar BL, Kakkar N, Verma A, et al. Prostatic hyperplasia in acromegaly, a myth or reality: A case-control study. Eur J Endocrinol. 2015;172:97\u2013106.","journal-title":"Eur J Endocrinol"},{"key":"9721_CR45","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/S0140-6736(04)16044-3","volume":"363","author":"AG Renehan","year":"2004","unstructured":"Renehan AG, Zwahlen M, Minder C, O\u2019Dwyer ST, Shalet SM, Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: Systematic review and meta-regression analysis. Lancet. 2004;363:1346\u201353.","journal-title":"Lancet"},{"key":"9721_CR46","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1530\/ERC-16-0553","volume":"24","author":"M Terzolo","year":"2017","unstructured":"Terzolo M, Reimondo G, Berchialla P, Ferrante E, Malchiodi E, De Marinis L, et al. Acromegaly is associated with increased cancer risk: A survey in Italy. Endocr Relat Cancer. 2017;24:495\u2013504.","journal-title":"Endocr Relat Cancer"},{"key":"9721_CR47","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1530\/EJE-12-0084","volume":"167","author":"M Arosio","year":"2012","unstructured":"Arosio M, Reimondo G, Malchiodi E, Berchialla P, Borraccino A, De Marinis L, et al. Predictors of morbidity and mortality in acromegaly: An Italian survey. Eur J Endocrinol. 2012;167:189\u201398.","journal-title":"Eur J Endocrinol"},{"key":"9721_CR48","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1210\/jc.2017-02457","volume":"103","author":"J Dal","year":"2018","unstructured":"Dal J, Leisner MZ, Hermansen K, Farkas DK, Bengtsen M, Kistorp C, et al. Cancer incidence in patients with acromegaly: A cohort study and meta-analysis of the literature. J Clin Endocrinol Metab. 2018;103:2182\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"9721_CR49","first-page":"17","volume":"30","author":"N Fiore","year":"2016","unstructured":"Fiore N. Clinical update: Prostate cancer. Nurs Stand. 2016;30:17.","journal-title":"Nurs Stand"},{"key":"9721_CR50","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/sj.ijir.3901483","volume":"19","author":"M Nickel","year":"2007","unstructured":"Nickel M, Moleda D, Loew T, Rother W, Pedrosa GF. Cabergoline treatment in men with psychogenic erectile dysfunction: A randomized, double-blind, placebo-controlled study. Int J Impot Res. 2007;19:104\u20137.","journal-title":"Int J Impot Res"},{"key":"9721_CR51","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1365-2265.2006.02461.x","volume":"64","author":"M De Rosa","year":"2006","unstructured":"De Rosa M, Ciccarelli A, Zarrilli S, Guerra E, Gaccione M, Di Sarno A, Lombardi G, Colao A. The treatment with cabergoline for 24 month normalizes the quality of seminal fluid in hyperprolactinaemic males. Clin Endocrinol. 2006;64:307\u201313.","journal-title":"Clin Endocrinol"},{"key":"9721_CR52","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1046\/j.1464-410x.1998.00520.x","volume":"81","author":"S Kapicioglu","year":"1998","unstructured":"Kapicioglu S, Mollamehmetoglu M, Kutlu N, Can G, Ozgur GK. Inhibition of penile erection in rats by a long-acting somatostatin analogue, octreotide (SMS 201\u2013995). Br J Urol. 1998;81:142\u20135.","journal-title":"Br J Urol"},{"key":"9721_CR53","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0093-691X(02)01361-4","volume":"60","author":"JE Aurich","year":"2003","unstructured":"Aurich JE, Kranski S, Parvizi N, Aurich C. Somatostatin treatment affects testicular function in stallions. Theriogenology. 2003;60:163\u201374.","journal-title":"Theriogenology"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-022-09721-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11154-022-09721-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-022-09721-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T17:23:04Z","timestamp":1668273784000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11154-022-09721-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,1]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["9721"],"URL":"https:\/\/doi.org\/10.1007\/s11154-022-09721-0","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,1]]},"assertion":[{"value":"22 March 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2022","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original version of this paper was updated to add the missing Open Access funding information in the Funding Note.","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies conducted in this article do not involve human participants or animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}